Cargando…
Post‐sequelae symptoms and comorbidities after COVID‐19
The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID‐19) are poorly understood, especially in community settings. To better understand and characterize symptoms months after community‐based COVID‐19, a retrospective cohort analysis was conducted. Three hundred and twen...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958980/ https://www.ncbi.nlm.nih.gov/pubmed/35032030 http://dx.doi.org/10.1002/jmv.27586 |
_version_ | 1784677055639584768 |
---|---|
author | Duggal, Priya Penson, Tristan Manley, Hannah N. Vergara, Candelaria Munday, Rebecca M. Duchen, Dylan Linton, Elizabeth A. Zurn, Amber Keruly, Jeanne C. Mehta, Shruti H. Thomas, David L. |
author_facet | Duggal, Priya Penson, Tristan Manley, Hannah N. Vergara, Candelaria Munday, Rebecca M. Duchen, Dylan Linton, Elizabeth A. Zurn, Amber Keruly, Jeanne C. Mehta, Shruti H. Thomas, David L. |
author_sort | Duggal, Priya |
collection | PubMed |
description | The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID‐19) are poorly understood, especially in community settings. To better understand and characterize symptoms months after community‐based COVID‐19, a retrospective cohort analysis was conducted. Three hundred and twenty‐eight consecutive persons with a positive test for SARS‐CoV‐2 in the Johns Hopkins Health System, Maryland, March−May 2020, were selected for the study. Symptom occurrence and severity were measured through questionnaires. Of 328 persons evaluated, a median of 242 days (109−478 days) from the initial positive SARS‐CoV‐2 test, 33.2% reported not being fully recovered and 4.9% reported symptoms that constrained daily activities. Compared to those who reported being fully recovered, those with post‐acute sequelae were more likely to report a prior history of heart attack (p < 0.01). Among those reporting long‐term symptoms, men and women were equally represented (men = 34.8%, women = 34.6%), but only women reported symptoms that constrained daily activities, and 56% of them were caregivers. The types of new or persistent symptoms varied, and for many, included a deviation from prior COVID‐19 health, such as being less able to exercise, walk, concentrate, or breathe. A limitation is that self‐report of symptoms might be biased and/or caused by factors other than COVID‐19. Overall, even in a community setting, symptoms may persist months after COVID‐19 reducing daily activities including caring for dependents. |
format | Online Article Text |
id | pubmed-8958980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89589802022-04-19 Post‐sequelae symptoms and comorbidities after COVID‐19 Duggal, Priya Penson, Tristan Manley, Hannah N. Vergara, Candelaria Munday, Rebecca M. Duchen, Dylan Linton, Elizabeth A. Zurn, Amber Keruly, Jeanne C. Mehta, Shruti H. Thomas, David L. J Med Virol Research Articles The frequency, severity, and forms of symptoms months after coronavirus 2019 (COVID‐19) are poorly understood, especially in community settings. To better understand and characterize symptoms months after community‐based COVID‐19, a retrospective cohort analysis was conducted. Three hundred and twenty‐eight consecutive persons with a positive test for SARS‐CoV‐2 in the Johns Hopkins Health System, Maryland, March−May 2020, were selected for the study. Symptom occurrence and severity were measured through questionnaires. Of 328 persons evaluated, a median of 242 days (109−478 days) from the initial positive SARS‐CoV‐2 test, 33.2% reported not being fully recovered and 4.9% reported symptoms that constrained daily activities. Compared to those who reported being fully recovered, those with post‐acute sequelae were more likely to report a prior history of heart attack (p < 0.01). Among those reporting long‐term symptoms, men and women were equally represented (men = 34.8%, women = 34.6%), but only women reported symptoms that constrained daily activities, and 56% of them were caregivers. The types of new or persistent symptoms varied, and for many, included a deviation from prior COVID‐19 health, such as being less able to exercise, walk, concentrate, or breathe. A limitation is that self‐report of symptoms might be biased and/or caused by factors other than COVID‐19. Overall, even in a community setting, symptoms may persist months after COVID‐19 reducing daily activities including caring for dependents. John Wiley and Sons Inc. 2022-01-31 2022-05 /pmc/articles/PMC8958980/ /pubmed/35032030 http://dx.doi.org/10.1002/jmv.27586 Text en © 2022 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Duggal, Priya Penson, Tristan Manley, Hannah N. Vergara, Candelaria Munday, Rebecca M. Duchen, Dylan Linton, Elizabeth A. Zurn, Amber Keruly, Jeanne C. Mehta, Shruti H. Thomas, David L. Post‐sequelae symptoms and comorbidities after COVID‐19 |
title | Post‐sequelae symptoms and comorbidities after COVID‐19 |
title_full | Post‐sequelae symptoms and comorbidities after COVID‐19 |
title_fullStr | Post‐sequelae symptoms and comorbidities after COVID‐19 |
title_full_unstemmed | Post‐sequelae symptoms and comorbidities after COVID‐19 |
title_short | Post‐sequelae symptoms and comorbidities after COVID‐19 |
title_sort | post‐sequelae symptoms and comorbidities after covid‐19 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958980/ https://www.ncbi.nlm.nih.gov/pubmed/35032030 http://dx.doi.org/10.1002/jmv.27586 |
work_keys_str_mv | AT duggalpriya postsequelaesymptomsandcomorbiditiesaftercovid19 AT pensontristan postsequelaesymptomsandcomorbiditiesaftercovid19 AT manleyhannahn postsequelaesymptomsandcomorbiditiesaftercovid19 AT vergaracandelaria postsequelaesymptomsandcomorbiditiesaftercovid19 AT mundayrebeccam postsequelaesymptomsandcomorbiditiesaftercovid19 AT duchendylan postsequelaesymptomsandcomorbiditiesaftercovid19 AT lintonelizabetha postsequelaesymptomsandcomorbiditiesaftercovid19 AT zurnamber postsequelaesymptomsandcomorbiditiesaftercovid19 AT kerulyjeannec postsequelaesymptomsandcomorbiditiesaftercovid19 AT mehtashrutih postsequelaesymptomsandcomorbiditiesaftercovid19 AT thomasdavidl postsequelaesymptomsandcomorbiditiesaftercovid19 |